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Summary
Background Antenatal factors including maternal diet may predispose to airway disease,
possibly by impacting on fetal airway development.
Objective This cohort study tested the hypothesis that maternal vitamin D and E status in
early pregnancy is associated with airway epithelial cell (AEC) responses in new born
infants and examined constitutive and TNFa/IL-1b, house dust mite (HDM) extract or
lipopolysaccharide (LPS)-stimulated neonatal AEC responses in vitro.
Methods Maternal dietary vitamin D and E intakes (plasma 25[OH]D3 or a-tocopherol)
were characterized at 10–12 weeks gestation. Neonatal nasal AECs were collected soon
after birth and cultured to tertiary passage. Constitutive and stimulated – TNFa/IL-1b,
HDM extract or LPS – secretory responses (VEGF, RANTES, MCP-1, IL-17A, IFN-c, GM-
CSF, eotaxin, MIP1-a, MIP1-b, ICAM, IL-6, IL-8, IL-10, TNF) in 139 AEC cultures were
quantified.
Results AEC mediator release was greater following TNF-a/IL-1b, HDM or LPS stimulation
compared to constitutive release. Increased maternal dietary vitamin D was associated with
significant increases in IL-10 release by AEC after stimulation with TNF-a/IL-1b
(P = 0.024) or HDM (P = 0.049). Maternal plasma a-tocopherol at 10–12 weeks gestation
was positively associated with MIP1a (Spearman’s rho 0.242, P = 0.009) and IL-3 (q 0.189,
P = 0.043) responses after TNF-a/IL-1b stimulation and negatively associated with TNF (q
-0.404, P = 0.011) and MIP1b (q -0.322, P = 0.046) responses after LPS stimulation.
Discussion Neonatal AECs respond to pro-inflammatory and allergenic stimuli in vitro
demonstrating their potential to function as components of the innate immune response.
Our findings suggest that associations exist between maternal micronutrient intake during
early pregnancy and aspects of stimulated neonatal airway epithelial cell secretory func-
tion that may in turn impact on the development of asthma and/or allergic rhinitis in
later life.
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Introduction
The airway epithelium plays critical roles in the initia-
tion, orchestration and perpetuation of the airway
immune and inflammatory responses of asthma. There
is much evidence demonstrating it to be structurally
and functionally abnormal in asthma [1]. However,
what is not known is when these abnormalities develop,
but given the importance of early life factors, it seems
likely that they develop early, possibly in utero. Such
developmental programming of airway epithelial cell
(AEC) function at a time of rapid lung growth and
remodelling has the potential to establish a life course
of abnormal airway epithelial cell function, airway
structure and function.
The potential importance of maternal diet during
pregnancy has been highlighted by studies reporting
associations between reduced maternal vitamin D [2–6]*Joint senior authors
and vitamin E [7–9] intake during pregnancy with
increased risk of childhood asthma and/or wheezing ill-
ness [10]. Both micronutrients have the potential to
exert immune-modulatory effects [11, 12]; however,
given the importance of AEC in asthma pathogenesis, it
is plausible that these antenatal exposures might impact
on fetal AEC development and neonatal AEC function.
Conventionally, lower respiratory tract AECs are
obtained bronchoscopically; however, in neonates, such
an approach is precluded by practical and ethical issues.
In contrast, the nose is a relatively non-invasive, read-
ily accessible source of AEC, and these have been vali-
dated as surrogates for bronchial AEC [13, 14]. More
recently, we developed a method to harvest and culture
AEC from the noses of neonates within the 48 hours of
birth [15]. These AECs, which are essentially ‘na€ıve’ and
yet to be exposed to the modifying effects of inhaled
environmental pollutants and pathogens, provide a
unique tool to gain insight into the role of antenatal
influences on airway development and the pathogenesis
of asthma and allergic rhinitis. This study tested the
hypothesis that maternal vitamin D and E intake during
pregnancy is associated with neonatal AEC function. To
do this, in vitro constitutive and stimulated inflamma-
tory mediator release by cultured neonate nasal AEC
was quantified and related to maternal vitamin D and E
intake during pregnancy.
Methods
Subjects and study design
In this cohort study, maternal vitamin D and E intake
and plasma status in early pregnancy were related to
the airway epithelial cell responses of their infants soon
after birth. Healthy pregnant women attending Aber-
deen Maternity Hospital for a routine ‘dating’ ultra-
sound scan at 10–12 weeks gestation were invited to
participate. Women were recruited regardless of their
smoking status or personal/family history of asthma or
atopic disease. An interviewer administered a question-
naire to establish smoking history, personal/family his-
tory of asthma and atopic disease and socio-economic
status (SES, Scottish Index of Multiple Deprivation).
Women were invited to complete semi-qualitative food
frequency questionnaire (FFQ, version 6.6 of the Scot-
tish Collaborative Group Food Frequency Questionnaire)
[16]. In women of childbearing age, the correlation
coefficients between intakes of vitamin D and E derived
by this questionnaire and 4-day weighed records were
0.38 (P < 0.001] and 0.52 (P < 0.001], respectively [16].
A non-fasted venous blood sample was collected.
Plasma a-tocopherol (adjusted for cholesterol) was
quantified by HPLC, [17] total 25-hydroxyvitamin D3
(25[OH]D3) by HPLC–tandem mass spectrometry [18]
and cotinine (an objective measure of tobacco smoke
exposure) by liquid chromatography-tandem mass spec-
trometry [19].
The study was approved by the North of Scotland
Research Ethics Service (ref 10/S0802/55), and all
women provided written informed consent.
Neonatal AEC sampling and culture
Nasal AECs were harvested from healthy, non-sedated
neonates at the earliest opportunity after birth. Exclusion
criteria for sampling were premature delivery (i.e.
<36 weeks gestation), admission to the neonatal unit and
presence of group B Streptococcus on maternal cervical
swab. Nasal AECs were sampled by brushing both nostrils
with an interdental brush and cultured to tertiary conflu-
ent monolayers and their epithelial phenotype confirmed
as previously described [15]. Cultured cells were used for
a variety of applications. Semi-quantitative membrane
arrays were first used to determine which cytokines or
chemokines were secreted by neonatal AEC constitutively
or following stimulation (data not shown). From these
experiments, a panel of cytokines and chemokines
deemed to be of relevance was chosen for quantitative
measurement in AEC supernatants. Mediator release was
measured in cell supernatants as in our earlier studies
using either ELISA (IL-8) or cytometric bead array (CBA)
analysis (VEGF, RANTES, MCP-1, IL-17A, IFN-c, GM-
CSF, eotaxin, MIP1-a, MIP1-b, ICAM, IL-6, IL-10, TNF).
Constitutive/basal mediator release was determined from
AEC at rest together with measurement of mediator
release from AEC exposed in vitro to pro-inflammatory,
environmental and allergic stimuli for 24 hours using
previously reported protocols [13–15]. Briefly, confluent
nasal AEC tertiary monolayers in 3.5 cm² wells were left
unstimulated or treated for 24 h with one of the follow-
ing: interleukin 1b (IL-1b) in combination with tumour
necrosis factor-a (TNF-a) (both at 10 ng/mL, R&D,
Abingdon, UK), 25 lg/mL house dust mite extract (HDM)
(Greer Laboratories, Lenoir, NC, USA) or 100 μg/mL lipo-
polysaccharide (LPS) (Sigma-Aldrich Ltd., Poole, UK). All
results were normalized to cellular protein content of
lysed monolayers quantified using the Bradford assay as
previously described [13–15].
Statistics
The primary outcome was nasal AEC cytokine and
chemokine release constitutively and after exposure to
the various described stimuli. Responses to stimuli were
computed by subtracting the constitutive unstimulated
values. The distribution of virtually all of the cytokine
and chemokine values did not approximate to normal
or log-normal distributions; consequently, nonparamet-
ric methods were used.
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The primary exposures of interest were maternal vita-
min D and E intakes. For vitamin D and E intakes,
dietary and supplement intakes were summated, energy
adjusted [20] and divided into thirds. Secondary expo-
sures were plasma 25[OH]D3, a-tocopherol, maternal
asthma, atopic disease or smoking status. Plasma
a-tocopherol and 25[OH]D3 were logarithmically trans-
formed and adjusted for gestational age; a-tocopherol
was also adjusted for cholesterol. Nasal AEC constitu-
tive and stimulated cytokine and chemokine release
was related to maternal vitamin D and E intake and
plasma indices using the Jonckheere–Terpstra test and
Spearman correlation coefficients, respectively. Statisti-
cal analyses were performed using IBM SPSS Statistics for
Windows, version 20.0. (Armonk, NY, USA).
Results
In total, 269 pregnant women were recruited and nasal
samples were obtained from 192 (71%) neonates.
Details on the maternal, paternal and neonate charac-
teristics together with nasal AEC culture success rate
are presented in Table 1. There were no significant
biases in the maternal characteristics of the neonates
sampled and the neonates from whom AECs were suc-
cessfully cultured. Neonates sampled and those with
successful AEC culture had greater birthweight. AEC
culture was more successful where samples were taken
in younger neonates (Table 1). The median age at AEC
sampling was 26 h (IQR, 16–45). Of the 192 nasal AEC
samples seeded, primary monolayers were established
from 164 (85%) samples, with 139 (72%) of samples
successfully cultured to confluence at third passage. Of
the mediators quantified, we observed relatively high
constitutive secretion of GM-CSF, ICAM-1, IL-6, IL-8
and VEGF with relatively low levels of MCP-1 and
RANTES by neonate AEC. AECs from 134 infants were
exposed to TNF-a/IL-1b, 106 to HDM and 53 to LPS.
Mediator release was greater after culture with all three
stimuli compared to basal/constitutive release
(Tables 2–4).
No significant associations were found between
secretion of any of the mediators measured from neo-
natal AEC and maternal history of asthma or atopic dis-
ease, maternal smoking status or plasma cotinine, or
mode of delivery (data not shown).
Vitamin D
Estimates of maternal vitamin D intake were positively
associated with maternal plasma 25[OH]D3 levels
(Spearman’s rho 0.278, P = 0.001). Women were
recruited year round, and although plasma 25[OH]D3
levels varied with season, being lowest in the winter
Table 1. Maternal, paternal and neonatal characteristics of recruited women and the neonates sampled and those from whom AECs were success-
fully cultured and analysed
Recruited (n = 269) Neonates sampled (n = 192) P* AEC cultured (n = 139) P†
Maternal
Age (mean 95% CI) 31.0 (30.5–31.4) 31.1 (30.5–31.6) 0.664 30.9 (30.2–31.5) 0.618
First pregnancy (n, %) 158 (59%) 110 (57%) 0.379 76 (55%) 0.139
Smoker (n, %) 14 (5.2%) 9 (4.7%) 0.548 5 (3.6%) 0.275
SIMD (median, IQR) 5283 (5491–5993) 5290 (4766–6044) 0.800 5291 (4670–5925) 0.803
Age leaving full-time education (median IQR) 21 (18–23) 21 (17–23) 0.253 21 (18–23) 0.932
Asthma 67 (25%) 48 (25%) 1.000 34 (25%) 0.832
Eczema 48 (18%) 33 (17%) 0.624 20 (14%) 0.119
Hayfever 100 (37%) 72 (38%) 0.920 49 (35%) 0.469
Vitamin D intake (ug/d mean 95% CI)‡ 17.8 (15.3–20.3) 18.6 (15.4–21.8) 0.296 17.3 (14.8–19.7) 0.645
Vitamin E intake (mg/d mean 95% CI)‡ 17.3 (16.0–18.6) 17.7 (16.2–19.3) 0.249 17.6 (15.8–19.4) 0.594
Plasma 25 OH vitamin D (nmol/L mean 95% CI) 55.8 (52.7–58.9) 56.3 (52.6–60.0) 0.821 55.6 (51.4–59.7) 0.748
Plasma a-tocopherol (umol/L mean 95% CI) 16.6 (15.2–18.0) 16.3 (14.7–17.9) 0.575 15.6 (15.4–19.6) 0.180
Paternal
Asthma 56 (21%) 41 (21%) 0.781 26 (19%) 0.424
Eczema 30 (11%) 21 (11%) 0.804 14 (10%) 0.529
Hayfever 77 (29%) 52 (27%) 0.535 39 (28%) 0.613
Neonate
Female (n, %) 135 (50%) 96 (50%) 0.693 70 (50%) 0.894
Gestational age at delivery (days, median, IQR) 282 (276–288) 281 (277–287) 0.238 282 (277–288) 0.251
Weight (g, mean, 95% CI) 3527 (3466–3587) 3571 (3504–3638) 0.001 3604 (3530–3679) 0.003
Age when sampled (hrs, median, IQR) 26 (16–45) 24 (15–40) 0.015
*Comparator, those that were not sampled, Chi2, unpaired t-tests, Mann–Whitney U-test.
†Comparator, those with unsuccessful AEC culture, Chi2, unpaired t-tests, Mann–Whitney U-test.
‡Energy adjusted.
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50.7 nmol/L (95% CI 39.6–61.8) and highest in the
summer 60.4 nmol/L (95% CI 52.1–68.6), this was not
statistically significant (P = 0.174). There were no
associations between maternal plasma 25[OH]D3 at
10–12 weeks gestation and constitutive AEC mediator
release; however, increasing maternal dietary vitamin D
intake was associated with decreasing IL-3 release,
P < 0.001 (Fig. 1).
There were no associations between maternal plasma
25[OH]D3 at 10–12 weeks gestation and AEC mediator
release after stimulation with LPS; however, increasing
maternal vitamin D intake was associated with signifi-
cant increases in IL-10 release by neonate nasal AEC
after stimulation with TNF-a/IL-1b (P = 0.024) or HDM
(P = 0.049) (Fig. 2).
Table 2. Airway epithelial cell release of cytokines/chemokines before











Eotaxin 0 (0–0) 0 (0–2) <0.001
GM-CSF 32.1 (7.8–171) 693 (267–1582) <0.001
ICAM 72.9 (0–216) 1268 (674–2064) <0.001
IFN- c 0 (0–1) 0 (0–3) 0.025
IL-3 0 (0–2) 0 (0–1) 0.241
IL-6 3434 (613–10 260) 27 670 (9874–56 920) <0.001
IL-8 6690 (3570–14 150) 107 600 (69 320–156 700) <0.001
IL-10 0 (0–0.9) 0 (0–1.26) 0.561
IL-17A 0 (0–0.2) 0 (0–2) 0.010
MCP-1 3.4 (0–5.7) 909 (272–2727) <0.001
MIP-1a 0 (0–4) 0 (0–20) 0.014
MIP-1b 0 (0–0) 55.9 (18–184) <0.001
RANTES 2.7 (0–6.1) 120.9 (30.9–36.6) <0.001
VEGF 2067 (1020–3739) 4193 (2381–5775) <0.001
*Wilcoxon signed-rank test.
†Values stated are median (IQR) mediator release expressed as pg per
mg protein content of the confluent cellular monolayer.
Table 3. Airway epithelial cell release of cytokines/chemokines before










Eotaxin 0 (0–0) 0 (0–2.8) <0.001
GM-CSF 31.9 (4.7–259.5) 108.2 (18.8–454) <0.001
ICAM 59.1 (0–192.9) 206.5 (31.1–610.9) <0.001
IFN- c 0 (0–0) 1. 6 (0–6.0) <0.001
IL-3 0 (0–0) 2.2 (0.2–9.6) <0.001
IL-6 5191 (91.7–14 226) 9045 (1036–28 700) <0.001
IL-8 6310 (1690–14 290) 17 510 (6580–37 025) <0.001
IL-10 0 (0–0) 1.6 (0–4.4) <0.001
IL-17A 0 (0–0) 1.1 (0–5.7) <0.001
MCP-1 5.3 (0–168) 36.1 (8.1–207.7) 0.011
MIP-1a 0 (0–0) 1.0 (0–11.2) <0.001
MIP-1b 0 (0–0) 0 (0–1.1) <0.001
RANTES 3.9 (2.3–6.8) 3.1 (1.2–7.3) 0.859
TNF 0 (0–0) 10.7 (4.8–18.6) <0.001
VEGF 3277 (1896–5203) 2944 (1827–4309) 0.428
*Wilcoxon signed-rank test.
†Values stated are median (IQR) mediator release expressed as pg per
mg protein content of the confluent cellular monolayer.
Table 4. Airway epithelial cell release of cytokines/chemokines before










Eotaxin 0 (0–0) 0 (0–0) 0.133
GM-CSF 30.6 (6.7–145.8) 73.1 (9.9–330) <0.001
ICAM 57.5 (0–142.5) 271.4 (48.7–668) <0.001
IFN- c 0 (0–0.8) 0 (0–0.3) 0.920
IL-3 0 (0–1.2) 3.3 (0.2–7.1) <0.001
IL-6 2350 (493–9629) 12 706 (699–26 212) <0.001
IL-8 5720 (3107–10 175) 15 355 (5695–30 713) <0.001
IL-10 0 (0–0.9) 0 (0–0.8) 0.460
IL-17A 0 (0–0.3) 0 (0–0.1) 0.648
MIP-1a 0 (0–4.2) 0 (0–3.2) 0.264
MIP-1b 0 (0–0) 0.4 (0–8.6) <0.001
MCP-1 1.3 (0–22.8) 29.1 (3.8–136.8) <0.001
RANTES 3.4 (0.5–6.4) 12.4 (2.9–71.7) <0.001
TNF 0 (0–1.5) 30.1 (3.0–124.8) <0.001
VEGF 2002 (1020–3579) 2340 (1066–3651) 0.372
*Wilcoxon signed-rank test.
†Values stated are median (IQR) mediator release expressed as pg per
mg protein content of the confluent cellular monolayer.
Fig. 1. Association between maternal vitamin D intake and constitu-
tive IL-3 release. P trend<0.001 (Jonckheere–Terpstra). *Values stated
are median (IQR) mediator release expressed as pg per mg protein
content of the confluent cellular monolayer.
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Vitamin E
Estimates of maternal vitamin E intake were positively
associated with maternal plasma a-tocopherol levels
(Spearman’s rho 0.206, P = 0.019). There were no asso-
ciations between maternal dietary vitamin E intake and
constitutive mediator release. Maternal plasma
a-tocopherol at 10–12 weeks gestation was associated
with decreasing constitutive release of TNF (Spearman’s
q -0.225, P = 0.014), MIP-1a (q -0.242, P = 0.008),
MIP1b (q -0.204, P = 0.027) and IL-3 (q -0.198,
P = 0.032).
There were no significant associations seen between
maternal vitamin E intake and mediator release by
neonate nasal AEC after stimulation. Maternal plasma
a-tocopherol at 10–12 weeks gestation was, however,
associated with increasing MIP1a (Spearman’s q 0.242,
P = 0.009) and IL-3 (q 0.189, P = 0.043) responses after
stimulation with TNF-a/IL-1b and with decreasing TNF
(q -0.404, P = 0.011) and MIP1b (q -0.322, P = 0.046)
responses after stimulation with LPS.
Discussion
We have recently described a safe, minimally invasive
and reliable method of culturing nasal AEC from neo-
nates [15]. Here, we extend these observations demon-
strating constitutive release of and up-regulation of
inflammatory mediator release in response to TNFb/IL-
1a, HDM extract or LPS stimuli by AEC cultured from
substantial numbers of neonates. These findings dem-
onstrate essentially naive AEC potentially function as
components of the innate immune response and
contribute to adaptive immune responses. We explored
determinants of neonatal AEC mediator release with a
focus on maternal dietary vitamin D and E exposures
during early pregnancy. The main finding was that
maternal vitamin D and E parameters were associated
with AEC responses in the setting of encountering
common environmental exposures. We observed signif-
icant associations between increasing vitamin D intake
and decreasing constitutive release of the pro-inflam-
matory cytokine IL-3 and increased secretion of the
anti-inflammatory cytokine IL-10 by IL-1b/TNF-a- or
HDM-stimulated neonate nasal AEC. Taken together,
these findings suggest that an antenatal environment
deficient in dietary vitamin D may lead to an exagger-
ated AEC inflammatory response in the context of
post-natal infection and allergen exposure, leading to
increased risk for asthma. Observational studies have
consistently reported lower maternal vitamin D intake
during pregnancy to be associated with an increased
risk of wheeze, asthma, eczema and atopic sensitiza-
tion in children up to the age of 5 years [2–4]. In con-
trast, maternal and/or umbilical cord 25[OH]D3 has
been reported to be either not associated [21],
adversely associated [22] or beneficially [5, 6] associ-
ated with respiratory and/or atopic outcomes up to the
age of 9 years. These apparently inconsistent associa-
tions may be explained by our study where an interac-
tion between antenatal (dietary) ‘priming’ plus
post-natal (infective or allergen) exposures are relevant
to the later development of symptoms. Vitamin D is
thought to influence both innate and adaptive immune
responses [23] and may also exert anti-inflammatory
effects in asthma as in vitro 1,25(OH)2D3 has been
shown to increase IL-10 secretion by human B cells
[24], regulatory T cells [25] and dendritic cells [26].
Here, we show for the first time a potential in vivo
anti-inflammatory effect by vitamin D on IL-10 secre-
tion by neonate AEC that may be relevant to the
development of immunological tolerance upon first
exposure of the airways to environmental insults [27,
28]. Previous work has demonstrated that vitamin D is
important in fetal lung alveolarization and surfactant
production in rats [29, 30]. Vitamin D also has com-
plex effects on surfactant production in alveolar [31]
or fibroblast cell lines [32]. Our findings suggest that
vitamin D influences human fetal AEC development.
The associations we present between maternal
a-tocopherol and AEC mediator release are less
straightforward than those for vitamin D intake but
may give insight into interactions between ante and
post-natal exposures. In the context of simulated viral
infection (TNFa/IL1b simulation), maternal plasma a-
tocopherol was positively correlated with release of the
pro-inflammatory mediators MIP1a and IL-3. In con-
trast, increasing plasma a-tocopherol was associated
Fig. 2. Association between maternal vitamin D intake and IL-10
release after stimulation with TNF-a/IL-1b and HDM. P-values com-
puted using Jonckheere–Terpstra test. *Values stated are median (IQR)
mediator release expressed as pg per mg protein content of the con-
fluent cellular monolayer.
© 2015 The Authors. Clinical & Experimental Allergy Published by John Wiley & Sons Ltd, 45 : 920–927
924 D. R. Miller et al
with a reduced pro-inflammatory response to simulated
bacterial infection (LPS), an association concordant with
the observation that early life endotoxin exposure is
associated with reduced likelihood of subsequent
asthma and atopic disease [33, 34]. Lower maternal die-
tary vitamin E intake during pregnancy is associated
with an increased risk of childhood wheezing [7, 8] and
asthma [9]. An association between maternal vitamin E
intake and in vitro responses by cord blood mononu-
clear cell responses [35] suggests that maternal vitamin
E may influence fetal immune development. Our novel
finding that plasma a-tocopherol at 10–12 weeks gesta-
tion modulates neonatal AEC mediator release suggests
effects on fetal AEC development, providing a further
mechanistic explanation for the relationship between
maternal dietary vitamin E intake and childhood
asthma.
In this study, maternal vitamin D intake, but not
plasma 25[OH]D3, was associated with neonatal AEC
inflammatory mediator release. This is analogous with
the epidemiological data outlined above whereby
maternal vitamin D intake but not plasma 25[OH]D3 is
consistently associated with childhood outcomes [2–6,
21, 22]. Dietary intake typically contributes about 10%
to UK vitamin D status, and whilst studies of plasma 25
[OH]D3 truly reflect associations with vitamin D status,
perhaps studies of vitamin D intake should be inter-
preted more broadly. Vitamin D is never naturally con-
sumed in isolation, but as foods containing many
nutrients; indeed, it may be the combination of natu-
rally associated nutrients that is important and should
perhaps be replicated in intervention studies. Trials of
vitamin D supplements during pregnancy are underway;
given the inconsistencies between dietary and plasma
vitamin D, these may not provide clear answers. In the
current study, maternal plasma a-tocopherol, but not
maternal vitamin E intake, was associated with neonatal
AEC inflammatory mediator release. A possible expla-
nation for this is that dietary vitamin E comprises natu-
ral isoforms, for example a- and c-tocopherol, and
there is evidence that these stereoisomers have different
biological effects; for example, in murine eosinophilic
allergic lung inflammation, a-tocopherol is anti-inflam-
matory, whereas c-tocopherol is pro-inflammatory [36].
The current prospective study is the first to culture
neonate AEC in substantial numbers and to relate medi-
ator release to antenatal exposures. Although the study
was hypothesis driven, the study was somewhat explor-
atory with many inflammatory mediators being quanti-
fied. The study has several limitations. The absence of
previous neonatal studies precluded meaningful consid-
eration of statistical power, and because we investigated
a wide range of potentially relevant mediators, the
reported associations may reflect the number of tests of
association conducted. The AECs cultured were nasal in
origin and not from the lower airways. However, it is
not ethically or physically possible to sample neonatal
bronchial epithelium. The micronutrient status of the
pregnant women was well characterized; however, the
inherent limitations of FFQ represent a null bias. In
addition, maternal nutrient status was quantified
30 weeks prior to the nasal AEC samples being
obtained. This and the time and processes taken to cul-
ture the AEC to tertiary passage constitute further null
bias. We were unable to demonstrate associations
between AEC mediator release and maternal smoking
and parental asthma, reflecting possibly the small num-
ber of women (n = 5) who smoked or had a history of
asthma (n = 34). Although we demonstrate associations
with several mediators, the quantities of some of these
mediators were small and IL-3 release was not signifi-
cantly increased by TNF-a/IL1-b exposure. The current
study had several strengths. Sample size was larger
than most studies of AEC in adults and older children;
moreover, by sampling healthy neonates within days of
birth, the AEC had not been influenced by post-natal
exposures such as pollution or infection. Further studies
will be needed to support or refute our findings and to
establish clinical relevance. Follow-up of the cohort is
envisaged to investigate whether the AECs of neonates
who develop childhood asthma differ from AECs of
children who do not. If so, it may be possible to use
neonatal nasal AECs in the clinical setting as a predic-
tive biomarker to quantify subsequent risk of asthma.
In summary, we have developed a reliable and repro-
ducible method to sample and culture nasal AECs from
substantial numbers of neonates. In addition, we have
demonstrated that neonatal AECs have the potential to
function as components of the innate immune response,
possibly directing adaptive immune responses to patho-
gens and allergens. Our findings are the first to demon-
strate associations between maternal micronutrient
intake during early pregnancy and aspects of stimulated
neonatal airway epithelial cell secretory function that
may in turn impact on the development of asthma and/
or allergic rhinitis in later life.
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